Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy

finance.yahoo.com/news/citigroup-says-obesity-drugmakers-stock-124500033.html

Key Points
-
The weight-loss drug market is already enormous, but could nearly double in size by 2035.
-
BioAge Labs is still years away from revenue and even more years away from actual profits.
-
Investors should understand that the stock's sizable potential upside comes paired with big…

This story appeared on finance.yahoo.com, 2025-11-05 12:45:00.
The Entire Business World on a Single Page. Free to Use →